4 years ago

SolasCure Raises £1.2 Million for Wound Cleaning Product

  • SolasCure, a Cambridge, UK-based biotech startup, raised £1.2 million in funding from Seneca Partners

  • The company intends to use the funds for the further development of its wound cleaning product, Aurase®

  • SolasCure is developing proprietary technology leveraging biomimicry and evidence-based medicine to empower healthcare professionals to treat patients with chronic wounds

  • Its first investigational product, Aurase®, is a hydrogel containing an enzyme cloned from medical maggots that can be used to support healthcare professionals treating patients with chronic wounds.

      • ProblemHealthcare

      "SolasCure is addressing the challenge of treating chronic wounds by developing a hydrogel containing an enzyme cloned from medical maggots, aiming to support healthcare professionals in this process."

      Solution

      "SolasCure offers Aurase®, a hydrogel product that contains an enzyme cloned from medical maggots, designed to aid healthcare professionals in treating patients with chronic wounds."

      Covered on